Cytology in Barrett's esophagus

Area of Science:

• Gastroenterology
• Cytopathology
• Oncology

Background:

• Brush cytology is a potential adjunct to endoscopic biopsy for Barrett's esophagus (BE) surveillance.
• Cytology offers advantages such as wider epithelial sampling, preferential exfoliation of dysplastic cells, simplicity, and lower cost.
• Current use of cytology in BE surveillance by US gastroenterologists is limited (17%), with insufficient data on its diagnostic utility.

Purpose of the Study:

• To evaluate the role and limitations of brush cytology in the diagnosis and surveillance of Barrett's esophagus.
• To explore the potential of integrating biomarkers with cytology to improve detection of low-grade dysplasia (LGD) and risk stratification.

Main Methods:

• Review of existing data on brush cytology's performance in detecting esophageal adenocarcinoma, high-grade dysplasia (HGD), and intestinal metaplasia (IM) in BE.
• Discussion of cytologic criteria for dysplasia and the feasibility of biomarker studies on cytologic specimens.
• Exploration of strategies to enhance cytology's sensitivity for LGD, including biomarker integration.

Main Results:

• Cytology demonstrates good sensitivity for adenocarcinoma and HGD, and good specificity for IM without dysplasia.
• Cytology may identify abnormalities missed by endoscopic biopsy.
• Cytology exhibits limitations in detecting low-grade dysplasia (LGD).

Conclusions:

• Brush cytology is a valuable tool in BE surveillance, complementing biopsy, but requires improved sensitivity for LGD.
• Integrating prognostic biomarkers into cytologic specimens could enhance risk stratification and support the utility of cytology in BE surveillance.
• Enhanced cytology with biomarkers could improve efficiency, risk stratification, and reduce costs in BE surveillance programs.